TRCT
ENFN

Tower Research Capital (TRC)’s Enfusion, Inc. ENFN Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,736
Closed -$19.4K – 5666
2025
Q1 		$19.4K Sell
1,736
-11,491
-87% -$127K ﹤0.01% 3002
2024
Q4 		$136K Buy
13,227
+4,889
+59% +$47.3K ﹤0.01% 1970
2024
Q3 		$79.1K Buy
8,338
+294
+4% +$2.54K ﹤0.01% 2419
2024
Q2 		$68.5K Buy
8,044
+7,118
+769% +$65.1K ﹤0.01% 2858
2024
Q1 		$8.57K Sell
926
-8,968
-91% -$78.9K ﹤0.01% 3999
2023
Q4 		$96K Buy
9,894
+8,627
+681% +$80.6K ﹤0.01% 2672
2023
Q3 		$11.4K Sell
1,267
-1,697
-57% -$16.1K ﹤0.01% 3999
2023
Q2 		$33.3K Sell
2,964
-9,818
-77% -$87K ﹤0.01% 2933
2023
Q1 		$135K Buy
12,782
+6,237
+95% +$68.7K ﹤0.01% 1612
2022
Q4 		$63K Buy
6,545
+4,013
+158% +$45.2K ﹤0.01% 2171
2022
Q3 		$32K Buy
2,532
+189
+8% +$2.31K ﹤0.01% 3564
2022
Q2 		$24K Buy
2,343
+1,371
+141% +$15.2K ﹤0.01% 3625
2022
Q1 		$12K Buy
972
+464
+91% +$7.09K ﹤0.01% 4111
2021
Q4 		$11K Buy
+508
New +$10.3K ﹤0.01% 4475

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s ENFN Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,736 shares — an estimated $19.4K sold.

Tower Research Capital (TRC) first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $136K in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,736 Enfusion, Inc. shares in Q2 2025, an estimated $19.4K.
  • Tower Research Capital (TRC) first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s Enfusion, Inc. position peaked at $136K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.